Show simple item record

dc.contributor.authorLevy, A.
dc.contributor.authorLe Péchoux, C
dc.contributor.authorFaivre-Finn, Corinne
dc.date.accessioned2021-07-28T12:42:39Z
dc.date.available2021-07-28T12:42:39Z
dc.date.issued2021en
dc.identifier.citationLevy A, Le Péchoux C, Faivre-Finn C. Twice-daily chemoradiotherapy in limited-stage small-cell lung cancer. The Lancet Oncology . 2021 Jun;22(6):e220.en
dc.identifier.pmid34087130en
dc.identifier.doi10.1016/s1470-2045(21)00255-2en
dc.identifier.urihttp://hdl.handle.net/10541/624373
dc.description.abstractNoneen
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1016/s1470-2045(21)00255-2en
dc.titleTwice-daily chemoradiotherapy in limited-stage small-cell lung canceren
dc.typeOtheren
dc.contributor.departmentDepartment of Radiation Oncology, Institut d'Oncologie Thoracique, Gustave Roussy, Villejuif, Franceen
dc.identifier.journalLancet Oncologyen
dc.description.noteen]


Files in this item

This item appears in the following Collection(s)

Show simple item record